US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Psyence Group Inc (PK) (PSYGF) 銘柄情報

Psyence Group Inc (PK) (PSYGF)

0.127

0.00

(0.00%)

終了 6月13日 5:00AM

Psyence Group Inc (PK) (PSYGF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.127

( - )

買値

0.127

売値

0.127

出来高

-

0.00 日の範囲 0.00

0.0992 52 週間の範囲 0.1394

時価総額

前日終値

0.127

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

15,638,267

配当利回り

PER

-

1 株当たり利益 (EPS)

-0.08

歳入

-

純利益

-1.1M

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops bota... Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

psyence.com

本社

Toronto, Canada

設立

2026

Psyence Group Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker PSYGF. The last closing price for Psyence (PK) was US$0.13. Over the last year, Psyence (PK) shares have traded in a share price range of US$ 0.0992 to US$ 0.1394.

Psyence (PK) currently has 15,638,267 shares in issue. The market capitalisation of Psyence (PK) is US$1.99 million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.127	0.127	0.127	0	0	CS
26	0	0	0.127	0.127	0.127	0	0	CS
52	0.0105	9.01287553648	0.1165	0.1394	0.0992	167	0.1097969	CS
156	-0.01285	-9.18841616017	0.13985	0.22	0.0046	53037	0.01737743	CS
260	-0.0768	-37.6840039254	0.2038	0.8921	0.0046	36889	0.01952481	CS

PSYGF - Frequently Asked Questions (FAQ)

What is the current Psyence Group Inc (PK) share price?

The current share price of Psyence Group Inc (PK) is US$ 0.127

How many Psyence Group Inc (PK) shares are in issue?

Psyence Group Inc (PK) has 15,638,267 shares in issue

What is the market cap of Psyence Group Inc (PK)?

The market capitalisation of Psyence Group Inc (PK) is USD 1.99M

What is the 1 year trading range for Psyence Group Inc (PK) share price?

Psyence Group Inc (PK) has traded in the range of US$ 0.0992 to US$ 0.1394 during the past year

What is the registered address of Psyence Group Inc (PK)?

The registered address for Psyence Group Inc (PK) is 121 Richmond Street West, Toronto, Ontario, M5H 2K1

What is the Psyence Group Inc (PK) website address?

The website address for Psyence Group Inc (PK) is psyence.com

Which industry sector does Psyence Group Inc (PK) operate in?

Psyence Group Inc (PK) operates in the Pharmaceuticals sector

Renee

PSYGF: effective April 23,2025 a one for 15 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

dirtydozen911

dirtydozen911 2年前

dont know why , but this P O S is up 125% at 30 mins ago scanner picked up low vol spike.

TooFrank

TooFrank 4年前

Colorado just legalized ‘magic mushrooms,’ an idea that’s growing nationwide

The initiative allows for the use of psilocybin at state-regulated centers under the supervision of licensed facilitators.
It also legalizes personal private use, growing and sharing of psilocybin and psilocin, as well as three additional psychedelic compounds — DMT, ibogaine and mescaline — by adults over the age of 21. Retail sales are not permitted,…

https://www.cnbc.com/amp/2022/11/12/colorado-just-legalized-magic-mushrooms-an-idea-thats-growing-nationwide.html

TooFrank

TooFrank 4年前

Hannam & Partners Financial Promotion of PSYGF

Psyence Group (PSYGF)
First mover into palliative care market supported
by natural psilocybin production
https://psyence.com/wp-content/uploads/2022/09/Psyence_Initiation_FINAL.02.pdf

Hannam & Partners Disclamer
https://www.hannam.partners/disclaimer/
Any Research Product is likely to be considered a financial promotion for the purposes of the FCA Rules.

Any Research Product provided by Hannam & Partners (“H&P”) will constitute “non-independent research” for the purposes of the rules from time to time of the Financial Conduct Authority (“FCA Rules”). As such it will constitute a marketing communication, has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

TooFrank

TooFrank 4年前

Psyence operates one of the first and only federally licensed commercial psilocybin production facilities in the world. Is licensed to cultivate and export psilocybin mushrooms for the legal, global medical market and commercial medical research market.

Preparing to send mushrooms to Canada and Spain for analysis and extraction.

The laboratory has also been expanded to having the capability and equipment to undertake in-process testing on site, crude extraction, as well as to generate Certificates of Analysis (COAs) and undertake testing of the end product.

TooFrank

TooFrank 4年前

Boom in psychedelic therapies

https://www.telegraph.co.uk/news/2022/08/20/magic-mushrooms-set-become-uks-ultimate-weapon-against-depression/

Edinburgh Uk Small Track

1111 Exploration

VanEck Genomics and Heal...

Permanent Master Issuer

Patrimoine Et Commerce

Lombard Medical Technologies

iShares Lithium & Batter...

British American Tobacco (PK)

abrdn Asia Pacific Incom... (PK)

International bond 2.5% ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。